NPPB and hydrops fetalis: Finally, in therapy optimization, Troughton et al. demonstrated that titration of therapy guided by NT-proBNP levels in symptomatic HF patients decreased hospital re-admission rates and cardiac mortality at 9.5 months follow-up, as compared to conventional follow up [14].